NEO Skin Clinic Ebisu Launches Next-Generation Skin Booster "Re2O / BNAJU"

NEO Skin Clinic Ebisu, managed by SBC Medical Group Holdings (Location: California, USA, CEO: Yoshiyuki Aikawa, hereinafter referred to as "SBC"), will begin offering the next-generation skin booster "Re2O / BNAJU" from Wednesday, April 1, 2026. This treatment is characterized by its ability to directly replenish external components such as collagen and elastin that support skin firmness and elasticity, representing a new concept in skincare treatment that differs from the conventional approach of "stimulating the skin to promote collagen production." It is expected to address complex skin concerns such as pores, firmness, fine lines, and dullness.

Skin firmness and elasticity are supported by the "foundation" of the dermis, which includes components like collagen, elastin, and hyaluronic acid. "Re2O / BNAJU" is a skin booster that directly replenishes these foundational skin components by injecting a high-purity preparation derived from human skin tissue*. By using a preparation from which cellular components that cause allergies have been removed, the design takes into account the reduction of the risk of foreign body reactions. Furthermore, with menus combining regenerative components (Rejuran) and moisturizing components (non-cross-linked hyaluronic acid), improvements in skin regenerative power, firmness, and radiance are also expected.

For details on "Re2O / BNAJU," please click here.

*1 This is what remains after removing cellular components from human skin, leaving only dermal components (extracellular matrix) such as collagen, elastin, and hyaluronic acid. *Side effects (risks) of the procedure: Individual differences exist in post-treatment redness, swelling, bruising, heat sensation, pain, etc.

Comments from Dr. Yuna Yoshikawa, Director of NEO Skin Clinic Ebisu

In anti-aging care, an approach that improves the foundation from the inside of the skin is extremely important. A major feature of "Re2O / BNAJU" is its ability to aim for the reconstruction of the skin's foundation itself by directly replenishing high-purity, human-derived components into the deep dermis. The preparation has had allergenic factors removed, is highly biocompatible, and its treatment design prioritizes safety. We believe it will be a valuable option for those with complex concerns such as pores, firmness, and dullness, or for those seeking more natural rejuvenation.

For details of Dr. Yoshikawa's profile, please click here.

SBC Medical Group continuously incorporates advanced medical knowledge from Japan and abroad while promoting improvements in knowledge and technical standards through specialized education. In the rapidly evolving field of cosmetic medicine, we will flexibly introduce new treatments utilizing the latest technologies, pursuing safety and reproducibility thoroughly under our unique rigorous verification system. Moving forward, we will strive for continuous improvement in safety, transparency, and value, based on global standards.

SBC Medical Group Holdings

SBC Medical Group Holdings is a Management Services Organization (MSO) providing management support to domestic and international medical institutions across a wide range of specialties including advanced cosmetic medicine, dermatology, orthopedics, fertility treatment, gynecology, dentistry, hair loss treatment (AGA), and ophthalmology. The group operates diverse clinic brands and is expanding globally into the US and Asia through medical tourism. Listed on the US NASDAQ market in September 2024, it was also selected for the US stock index "Russell 3000" in June 2025. Moving forward, we will promote the provision of highly reliable medical services and network expansion towards the realization of our group purpose: "Contributing to improving the "happiness level" of people worldwide through medical innovation."

English Name: SBC Medical Group Holdings Incorporated

Listed Market: NASDAQ Global Market

Ticker (US Stock Code): SBC

Location: 200 Spectrum Center Drive Suite 300 Irvine, CA 92618 USA

CEO: Yoshiyuki Aikawa

Business: Management support services for medical institutions (cosmetic medicine, dermatology, orthopedics, fertility treatment, gynecology, dentistry, hair loss treatment (AGA), ophthalmology, etc.)

Official Website: https://sbc-holdings.com

Official LinkedIn Page: https://www.linkedin.com/company/sbc-medical-group-holdings-inc

SBC Medical Group Recruitment Site: https://www.sbc-recruit.com

NEO Skin Clinic: https://www.sbc-neoskinclinic.jp/

【Contact Information for this Matter】

SBC Medical Group Holdings

Public Relations Department: Murakami Email: pr@sbc.or.jp